Please select the option that best describes you:
Topics:
Thoracic Malignancies • Medical Oncology
Will you offer lurbinectedin with atezolizumab for patients with ES-SCLC during maintenance if they had brain metastases at baseline?
Patients with baseline brain metastases were notably excluded from IMforte.